The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Next steps for IBM Watson Oncology: Scalability to additional malignancies.
Andrew S. Epstein
Employment or Leadership Position - Memorial Sloan-Kettering Cancer Center
Marjorie Glass Zauderer
Employment or Leadership Position - Memorial Sloan-Kettering Cancer Center
Ayca Gucalp
Employment or Leadership Position - Memorial Sloan-Kettering Cancer Center
Andrew David Seidman
Employment or Leadership Position - Memorial Sloan-Kettering Cancer Center
Aryeh Caroline
Employment or Leadership Position - Memorial Sloan-Kettering Cancer Center
Julia Fu
Employment or Leadership Position - IBM (I); Memorial Sloan-Kettering Cancer Center
Stock Ownership - IBM (I)
Jeffrey Keesing
Employment or Leadership Position - Memorial Sloan-Kettering Cancer Center
Stock Ownership - IBM (B)
Franny Hsiao
Employment or Leadership Position - IBM
Stock Ownership - IBM
Mark Megerian
Employment or Leadership Position - IBM
Stock Ownership - IBM
Thomas Eggebraaten
Employment or Leadership Position - IBM
Stock Ownership - IBM
Robert DeLima
Employment or Leadership Position - IBM
Stock Ownership - IBM
Marie Setnes
Employment or Leadership Position - IBM
Stock Ownership - IBM
Peter Bach
Employment or Leadership Position - Memorial Sloan-Kettering Cancer Center
Mark G. Kris
Employment or Leadership Position - Memorial Sloan-Kettering Cancer Center